Currently predicting for Thu, 4 Jun 2026

INCY Prediction Chart

INCY Predictions History

Latest community submissions for INCY.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 16, 2025 $87.30 -0.96% $87.31 V 99.99% 10
Oct 16, 2025 $87.62 -0.60% $87.31 V 99.65% 5
Oct 16, 2025 Bullish $87.31 V 0
Feb 18, 2025 $69.42 -1.42% $71.27 X 97.40% 0
Feb 18, 2025 $71.04 +0.89% $71.27 V 99.68% 5
Feb 18, 2025 $122.20 +74.55% $71.27 V 28.54% 1
AlexVel AlexVel Pro
Dec 12, 2023 $56.89 -0.26% $61.86 X 91.97% 0
RKP RKP Senior
Mar 23, 2023 $77.00 +6.56% $72.26 X 93.44% 0
RKP RKP Senior
Mar 22, 2023 $75.00 +2.05% $72.26 X 96.21% 0
RKP RKP Senior
Mar 21, 2023 $75.00 +1.05% $73.49 X 97.95% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INCY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT INCYTE CORPORATION
Incyte
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE